Navigation Links
Roads pave the way for the spread of superbugs
Date:9/29/2011

ANN ARBOR, Mich.---Antibiotic resistant E. coli was much more prevalent in villages situated along roads than in rural villages located away from roads, which suggests that roads play a major role in the spread or containment of antibiotic resistant bacteria, commonly called superbugs, a new study finds.

Many studies on various infectious diseases have shown that roads impact the spread of disease, however this is the first known study to show that roads also impact the spread of antibiotic resistant bacteria, said Joe Eisenberg, co-author and professor at the University of Michigan School of Public Health.

Researchers at the U-M SPH and colleagues from Universidad San Francisco de Quito, and Trinity College studied a region in northwest Ecuador for five years, focusing on antibiotic resistant E. coli and the common antibiotic paring of ampicillin and sulfamethoxazole.

"Our results show it's not just the individual's antibiotic use that affects antibiotic resistance," Eisenberg said. "Other important factors that affect the spread of antibiotic resistance are the rates at which people introduce new strains due to movement in and out of the region, as well as poor water quality and sanitation that allow for the transmission of antibiotic resistant strains." Both of these factors are influenced by the presence of the roads.

"We focus so much on the individual, and if they do or don't take antibiotics, but we're learning more and more that there's a broader environmental and social context in which antibiotic resistance happens," Eisenberg said.

While increased antibiotic use over long periods of time can increase antibiotic resistance with bacteria such as E. coli, when antibiotics are taken for much shorter periods of time, they have a different effect on bacteria.

For those bacteria, taking antibiotics amplifies antibiotic resistant bacteria that already exists in the individual, by k
'/>"/>

Contact: Laura Bailey
baileylm@umich.edu
734-355-2100
University of Michigan
Source:Eurekalert

0

GOOD

Page: 1 2

Related medicine news :

1. Cancer Drug Avastin Makes Inroads Against Ovarian Tumors
2. Special Assistants Making Inroads in Dentistry
3. Holiday Drinking Raises Death Toll on U.S. Roads, Experts Warn
4. Texting Taking a Deadly Toll on Roads
5. Africa cell phone boom beneficial -- but schools, roads, power, water remain critical needs
6. Eye movements and sight distance reveal how drivers negotiate winding roads
7. Crossroads for Growth Drawing Attention This World Autism Day to Help NJ Families Obtain Autism Treatment
8. More Familiar Roads More Dangerous for Drivers
9. MIT's Center for Transportation & Logistics Announces new Environmental Performance Consortium at Annual Crossroads Conference
10. Searchers map the global spread of drug-resistant influenza
11. Researchers investigate new mechanism for predicting how diseases spread
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2013)... Clinic researchers have used next generation genomic analysis to ... tumors have similar genetic origins, which may help in ... the journal Cancer Research . , "This is ... generation sequencing in adjacent Gleason patterns in the same ... pathology," says ,John Cheville, M.D., Mayo Clinic pathologist and ...
(Date:5/23/2013)... (PRWEB) May 23, 2013 Dr. Katherine ... new charitable organization in Orange County, OCCares , will ... Orange County. The event details are as follows: , ... Academy Auditorium, 13732 Clinton Street, Garden Grove, CA 92843 , ... crossover music by Christian vocalists Charmaine & Jonathan Thulin. ...
(Date:5/23/2013)... New York, NY (PRWEB) May 23, 2013 ... http://bit.ly/Z4m6UI , Canadian tech start-ups are increasingly seeing ... deals with larger US-based companies, according to ... business development engine. , The company has compiled ... entitled Borderless Investments. The findings of the research have ...
(Date:5/23/2013)... 23, 2013 Cheap Concert Tickets announces that ... of 2013 at stadiums throughout North America. This well ... Paul McCartney concert tickets to help McCartney fans see Sir ... Concert Tickets, states that she is also offering the customer ... Being a baby boomer, she is also a huge ...
(Date:5/23/2013)... THURSDAY, May 23 (HealthDay News) -- Symptoms of ... psychiatric disorders, complicating diagnosis and treatment. But researchers ... that may be unique to borderline personality disorder: ... face. , , "They have difficulty processing facial ... a neutral face," said Anthony Ruocco, a clinical ...
Breaking Medicine News(10 mins):Health News:Mayo Clinic genomic analysis lends insight to prostate cancer 2Health News:Dr. Katherine Ahn is Proud to Announce the Launch Her Family's New Charity OCCares 2Health News:Dr. Katherine Ahn is Proud to Announce the Launch Her Family's New Charity OCCares 3Health News:Merrill DataSite Releases New Comments: Trends amidst Canadian and US Tech M&A 2Health News:Merrill DataSite Releases New Comments: Trends amidst Canadian and US Tech M&A 3Health News:Merrill DataSite Releases New Comments: Trends amidst Canadian and US Tech M&A 4Health News:Paul McCartney Tickets: Prices Slashed on Paul McCartney Tickets in Austin, Brooklyn, Tulsa, Memphis Washington DC, Milwaukee, Boston, Indianapolis, Regina and Seattle 2Health News:People With Borderline Personality Disorder May Misinterpret Facial Emotions 2Health News:People With Borderline Personality Disorder May Misinterpret Facial Emotions 3
... Jan. 30 A report issued today by ... consultancy,based in Washington, D.C., confirms that Blue Cross ... to the people of Michigan in 2007 through,an ... improve access to,health coverage at affordable prices. The ...
... A new study of age-related macular degeneration (AMD), a disease ... way for the biopharmaceutical industry to develop better treatments and ... the research. , This is the first time that ... that closely represents the disease in people, said Stephen Rose, ...
... Caraco Pharmaceutical,Laboratories, Ltd. (Amex: CPD ) announced ... 40 mg (Pantoprazole Sodium,DR), which is AB-rated to ... Industries, Ltd. (Sun Pharma). Sun Pharma recently received,approval ... for its Abbreviated,New Drug Application (ANDA) for generic ...
... Mass., Jan. 30 Weston Medical Publishing ... of Disaster Medicine,( http://www.disastermedicinejournal.com ), sister publication ... ), has been accepted for,inclusion into the ... may,now be accessed through the PUBMED website ...
... chain attempted to silence union activist, CHICAGO, Jan. ... (NLRB) has issued an unfair labor practice complaint,against Resurrection ... at West Suburban Medical Center, an RHC-affiliated hospital. The,NLRB ... told a union,activist that he could no longer speak ...
... DELRAY BEACH, Fla., Jan. 30 More than 100 ... 25 at Diagnostic,Centers of America (DCA) Delray Beach medical ... cardiac and diagnostic,medical imaging, enabling physicians to obtain clearer ... to beat and without the need for beta blockers., ...
Cached Medicine News:Health News:Examination by National Expert Shows Blue Cross Blue Shield of Michigan's Social Mission Contributions Totaled at Least $391 Million in 2007 2Health News:Examination by National Expert Shows Blue Cross Blue Shield of Michigan's Social Mission Contributions Totaled at Least $391 Million in 2007 3Health News:Caraco Pharmaceutical Laboratories Ltd. to Market Generic Protonix(R) 2Health News:Caraco Pharmaceutical Laboratories Ltd. to Market Generic Protonix(R) 3Health News:American Journal of Disaster Medicine Accepted for Inclusion into The National Library of Medicine's MEDLINE Database and may now be Accessed Through the PUBMED Website or the MEDLARS System 2Health News:Labor Board Issues Complaint Against Resurrection Health Care 2Health News:Delray Beach Mayor Commemorates Diagnostic Centers of America (DCA) $2 Million Purchase from Siemens to Become Only Medical Facility in South Florida with World's Most Advanced Cardiac Scanner. 2
(Date:5/23/2013)...  Echo Pharma Acquisition Limited ("Royalty Pharma") announced today ... Threshold from 90 percent to 50 percent of Maximum ... with the terms of the Revised Offer Document issued ... Under the terms of the Increased Offer, Royalty Pharma ... ) for $12.50 per share in cash. The Increased ...
(Date:5/23/2013)... 23, 2013   BioLife Solutions , Inc. (OTC:BLFS), ... grade hypothermic storage and cryopreservation freeze ... aseptic media manufacturer , today announced its participation at ... Congress 2013 this week in London ... Dr. Aby J. Mathew, BioLife,s Senior Vice President ...
(Date:5/23/2013)... PARIS , May 23, 2013 /PRNewswire/ ... developer and manufacturer of precision guided therapy tools designed ... peripheral vascular disease, today announced preliminary results from the ... ndependent S tenosis E valuation) II trial ... at EuroPCR 2013. These prospective results confirm prior retrospective ...
Breaking Medicine Technology:Royalty Pharma Reduces Acceptance Condition to 50% Plus One Share 2Royalty Pharma Reduces Acceptance Condition to 50% Plus One Share 3Royalty Pharma Reduces Acceptance Condition to 50% Plus One Share 4Royalty Pharma Reduces Acceptance Condition to 50% Plus One Share 5Royalty Pharma Reduces Acceptance Condition to 50% Plus One Share 6Royalty Pharma Reduces Acceptance Condition to 50% Plus One Share 7Royalty Pharma Reduces Acceptance Condition to 50% Plus One Share 8Royalty Pharma Reduces Acceptance Condition to 50% Plus One Share 9Royalty Pharma Reduces Acceptance Condition to 50% Plus One Share 10BioLife Solutions Announces Presentation at 8th World Stem Cells & Regenerative Medicine Congress 2BioLife Solutions Announces Presentation at 8th World Stem Cells & Regenerative Medicine Congress 3Volcano Announces Preliminary Results from the ADVISE II Study and Inclusion in the SYNTAX2 Trial During Hot Line Late Breaking Clinical Trial Sessions at EuroPCR 2013 2Volcano Announces Preliminary Results from the ADVISE II Study and Inclusion in the SYNTAX2 Trial During Hot Line Late Breaking Clinical Trial Sessions at EuroPCR 2013 3Volcano Announces Preliminary Results from the ADVISE II Study and Inclusion in the SYNTAX2 Trial During Hot Line Late Breaking Clinical Trial Sessions at EuroPCR 2013 4Volcano Announces Preliminary Results from the ADVISE II Study and Inclusion in the SYNTAX2 Trial During Hot Line Late Breaking Clinical Trial Sessions at EuroPCR 2013 5
... CAMBRIDGE, Mass. , Feb. 4 Recognizing that ... information they contain, Northern Light ( www.northernlight.com ) today announced ... in excess of $2 billion can be searched, ... has been steadily increasing the number of market research sources ...
... , CARLSBAD, Calif. , Feb. 4 Genoptix, Inc. ... that it expects to report its financial results for the fourth quarter ... Thursday, February 25, 2010 . , A conference call hosted ... members of senior management will take place on the same day at ...
Cached Medicine Technology:Northern Light Surpasses $2 Billion Worth of Research Content Integrated Into SinglePoint Strategic Research Portals 2Northern Light Surpasses $2 Billion Worth of Research Content Integrated Into SinglePoint Strategic Research Portals 3Genoptix, Inc. to Announce Fourth Quarter and Full-Year 2009 Financial Results 2Genoptix, Inc. to Announce Fourth Quarter and Full-Year 2009 Financial Results 3
... The Pediatric BladderScan® ... to Diagnostic Ultrasound's trusted ... By enabling healthcare providers ... bladder volume noninvasively, this ...
... Bladder Monitor is a handheld, noninvasive ... provider to enable patients to monitor ... It is easy to use and ... patient can make informed decisions about ...
... The BladderScan BVM 6500 ... noninvasively to determine UEBW ... and bladder volume using ... BVM 6500 was designed ...
... Implant, the world's leading bulking therapy, is ... treatment of Stress Urinary Incontinence (SUI). Natural ... tissue to aid coaptation in a defective ... structure, Contigen Bard Collagen Implant forms a ...
Medicine Products: